Haemoglobin phenotypes and the risk of asymptomatic malaria parasitemia among blood donors in northwest Nigeria: clinical implications in the practice of tropical transfusion medicine

Background: In malaria-endemic populations, sickle cell trait (SCT) protects against both severe and non-severe malaria, but inconsistencies exist about protective effect of SCT on asymptomatic malarial parasitemia (AMP). Surprisingly, the effect of Hb-phenotypes on AMP has not been explored among blood donors in Nigeria or other malaria-endemic countries, where risks of AMP and transfusion transmitted malaria (TTM) are high. The objective of this study is to determine risk of AMP with respect to donor Hb-phenotypes (SCT versus HbAA), and elucidate clinical implications of AMP with respect to risk of TTM vis-à-vis the practice of transfusion medicine in Nigeria, and by implication other malaria-endemic tropical countries. Methodology: Analysis of 100 blood donors with AMP (cases) and 100 donors without AMP (controls) was performed. Frequencies of SCT and HbAA (determined by Hb electrophoresis) among cases and controls were compared by X-test. Risks of AMP (detected by microscopy) with respect to Hb-phenotypes were expressed as Odds ratios (OR) by case-control logistic regression. Results: In comparison with blood donor without AMP (controls), donors with AMP had lower frequencies of SCT (12% vs 28%, p<0.05) with corresponding higher frequencies of HbAA (88% vs 72%, p<0.05). HbAA is associated with high risk of AMP (OR=2.91, 95%CI: 2.10-3.48, p=0.021), while SCT is associated low risk of AMP (OR=0.49, 95%CI: 0.27-0.73, p=0.032). Conclusion: This finding shows that donor SCT is a surreptitious mitigator of the risk of AMP and TTM in the tropics. Therefore, patients who are selectively transfused with HbAA blood (e. g. neonates and sickle cell disease patients) could be at greater risks of TTM, and such patients need closer post transfusion monitoring. The risk of TTM calls for diligent post transfusion haemovigilance in Nigeria and other malaria endemic tropical countries in Africa

[1]  M. Davenport,et al.  Interaction between maternally derived antibodies and heterogeneity in exposure combined to determine time-to-first Plasmodium falciparum infection in Kenyan infants , 2019, Malaria Journal.

[2]  P. O. Olatunji Malaria and the Sickle Gene: Polymorphism Balance in favour of eradication , 2018, Annals of Health Research.

[3]  A. Frimpong,et al.  Safety and effectiveness of antimalarial therapy in sickle cell disease: a systematic review and network meta-analysis , 2018, BMC Infectious Diseases.

[4]  R. Naik,et al.  The current state of sickle cell trait: implications for reproductive and genetic counseling. , 2018, Hematology. American Society of Hematology. Education Program.

[5]  O. Ibegbulam,et al.  Pattern of blood donation and characteristics of blood donors in Enugu, Southeast Nigeria , 2018, Nigerian journal of clinical practice.

[6]  S. Stowell,et al.  Transfusion‐transmitted malaria masquerading as sickle cell crisis with multisystem organ failure , 2018, Transfusion.

[7]  W. Oyibo,et al.  Transfusional malaria in the neonatal period in Lagos, South-West Nigeria , 2018, PloS one.

[8]  N. Ibeh,et al.  Knowledge, attitude and practice of haemovigilance among healthcare professionals in a Nigerian Tertiary Hospital , 2017 .

[9]  O. A. Lawal,et al.  Blood transfusion services for patients with sickle cell disease in Nigeria. , 2016, International health.

[10]  J. Faruk Blood transfusion malaria: A literature review , 2016 .

[11]  D. Diallo,et al.  Transmission of Plasmodium falciparum by red blood cell transfusions in the management of sickle cell disease patients in Mali , 2016, Transfusion medicine.

[12]  P. E. Van den Steen,et al.  The immunological balance between host and parasite in malaria. , 2016, FEMS microbiology reviews.

[13]  N. Garba Distribution of Haemoglobin Variants , ABO and Rh Blood Groups in Blood Donors Attending Aminu Kano Teaching Hospital , 2016 .

[14]  O. Sonubi,et al.  Targeting Females as Voluntary Non Remunerated Donors in Developing Nations , 2015 .

[15]  F. Ayala,et al.  Malaria continues to select for sickle cell trait in Central Africa , 2015, Proceedings of the National Academy of Sciences.

[16]  K. Ibrahim,et al.  Female Gender Participation in the Blood Donation Process in Resource Poor Settings: Case study of Sokoto in North Western Nigeria , 2014 .

[17]  A. Adewoyin,et al.  Hypertransfusion Therapy in Sickle Cell Disease in Nigeria , 2014, Advances in hematology.

[18]  J. Aneke,et al.  Current sickle cell disease management practices in Nigeria. , 2014, International health.

[19]  P. Rosenthal,et al.  Biochemical and immunological mechanisms by which sickle cell trait protects against malaria , 2013, Malaria Journal.

[20]  F. McKenzie,et al.  Foetal haemoglobin and the dynamics of paediatric malaria , 2012, Malaria Journal.

[21]  S. Ahmed,et al.  The Role of Infection in the Pathogenesis of Vaso-Occlusive Crisis in Patients with Sickle Cell Disease. , 2011, Mediterranean journal of hematology and infectious diseases.

[22]  Sanjai Kumar,et al.  Survival of Plasmodium falciparum in human blood during refrigeration , 2011, Transfusion.

[23]  I. Danquah,et al.  Influence of haemoglobins S and C on predominantly asymptomatic Plasmodium infections in northern Ghana. , 2010, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[24]  U. Ibrahim,et al.  Haemoglobin‐S in sickle cell trait with papillary necrosis , 2006, British journal of haematology.

[25]  O. Gaye,et al.  Red blood cell polymorphisms in relation to Plasmodium falciparum asymptomatic parasite densities and morbidity in Senegal. , 2006, Microbes and infection.

[26]  B. Bain,et al.  Investigation of abnormal haemoglobins and thalassaemia , 2006 .

[27]  A. Hassan,et al.  The Frequency and Clinical Significance of Structural Haemoglobin Variants in Donor Blood at University of Maiduguri Teaching Hospital , 2000 .

[28]  R. Nagel,et al.  The pathophysiology of vascular obstruction in the sickle syndromes. , 1996, Blood reviews.

[29]  A. Fleming,et al.  Abnormal haemoglobins in the Sudan savanna of Nigeria. I. Prevalence of haemoglobins and relationships between sickle cell trait, malaria and survival. , 1979, Annals of tropical medicine and parasitology.

[30]  P. McCurdy,et al.  Red cell life span in sickle cell trait. , 1974, Acta haematologica.